Page last updated: 2024-08-17

bromodeoxyuridine and Cranial Nerve V Diseases

bromodeoxyuridine has been researched along with Cranial Nerve V Diseases in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Aita, M; Byers, MR; Chavkin, C; Xu, M	1

Other Studies

1 other study(ies) available for bromodeoxyuridine and Cranial Nerve V Diseases

Article	Year
Trigeminal injury causes kappa opioid-dependent allodynic, glial and immune cell responses in mice. Molecular pain, 2010, Jan-29, Volume: 6 Topics: Animals; Astrocytes; Biomarkers; Bromodeoxyuridine; CD11 Antigens; Cell Proliferation; Disease Models, Animal; Glial Fibrillary Acidic Protein; Gliosis; Hyperalgesia; Immunohistochemistry; Intermediate Filament Proteins; Ligation; Macrophages; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Microglia; Nerve Tissue Proteins; Nestin; Neuroglia; Receptors, Opioid, kappa; Trigeminal Ganglion; Trigeminal Nerve Diseases; Trigeminal Nuclei	2010

Article

Year

Trigeminal injury causes kappa opioid-dependent allodynic, glial and immune cell responses in mice.

Molecular pain, 2010, Jan-29, Volume: 6

Topics: Animals; Astrocytes; Biomarkers; Bromodeoxyuridine; CD11 Antigens; Cell Proliferation; Disease Models, Animal; Glial Fibrillary Acidic Protein; Gliosis; Hyperalgesia; Immunohistochemistry; Intermediate Filament Proteins; Ligation; Macrophages; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Microglia; Nerve Tissue Proteins; Nestin; Neuroglia; Receptors, Opioid, kappa; Trigeminal Ganglion; Trigeminal Nerve Diseases; Trigeminal Nuclei

2010